Placeholder Banner

BIO Applauds Senate Passage of the 21st Century Cures Act

December 7, 2016

Washington, DC (December 7, 2016) – Biotechnology Innovation Organization (BIO) President and CEO James C. Greenwood issued the following statement today regarding passage of the 21st Century Cures Act by the U.S. Senate:

“The 21st Century Cures Act, passed by the Senate today with overwhelming bipartisan support, is an important victory for medical innovation that will help expedite the development of the next generation of breakthrough medicines to save lives and reduce suffering for millions of patients, while helping to lower other healthcare costs.

“We applaud the work of the Senate for making sure that this important legislation remained a priority. We particularly want to recognize Senate Health, Education, Labor and Pensions (HELP) Chairman Lamar Alexander and Ranking Member Patty Murray, as well as the members of the Committee, for their tireless, bipartisan cooperation in crafting this important legislation. We urge President Obama to swiftly sign the Act into law.”

Read BIO’s letter in support of the 21st Century Cures Act here.

Upcoming BIO Events

BIO CEO & Investor Conference
February 13-14, 2017
New York, NY

BIO International Convention
June 19-22, 2017
San Diego, CA


###

Discover More
New focus on justice through equity in diverse clinical trials, STEM education and expanding entrepreneurship to undeserved communities will drive nation’s largest life science advocacy organization The Biotechnology Innovation Organization (BIO)…
Today, the Biotechnology Innovation Organization (BIO) submitted its comments in response to the U.S. Department of Agriculture’s (UDSA) Solicitation of Input from Stakeholders on Agricultural Innovations, part of the Department’s Agriculture…
Washington, D.C. (July 29, 2020) – The Food and Agriculture Section of the Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Board leadership. Sylvia Wulf, CEO of AquaBounty Technologies, Inc., and Brian…